| scholarly article | Q13442814 |
| P50 | author | Sang Youl Rhee | Q37383931 |
| Ja Min Byun | Q41549147 | ||
| Chang Kyun Lee | Q60311452 | ||
| Jaejun Shim | Q81688865 | ||
| Hyo-Jong Kim | Q86665359 | ||
| Jung-Wook Kim | Q86665361 | ||
| Jae Young Jang | Q86665366 | ||
| P2093 | author name string | Jae Young Jang | |
| Jung-Wook Kim | |||
| Chang Kyun Lee | |||
| Jae-Jun Shim | |||
| Sang Youl Rhee | |||
| Hyo-Jong Kim | |||
| Ja Min Byun | |||
| P2860 | cites work | Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Q22250934 |
| Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
| Diagnosis and Treatment of Latent Tuberculosis Infection due to Initiation of Anti-TNF Therapy | Q33882852 | ||
| Performance of Tuberculin Skin Test Measured against Interferon Gamma Release Assay as Reference Standard in Children | Q35128566 | ||
| TNF-blocking agents and tuberculosis: new drugs illuminate an old topic | Q36059141 | ||
| Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor | Q36705704 | ||
| Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. | Q36797710 | ||
| Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea | Q37221167 | ||
| Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. | Q37767584 | ||
| Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review | Q37832862 | ||
| Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. | Q37925683 | ||
| Opportunistic infections due to inflammatory bowel disease therapy | Q38139812 | ||
| Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. | Q38194708 | ||
| An Internet-based surveillance system for tuberculosis in Korea. | Q38450625 | ||
| Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study | Q38503949 | ||
| Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population. | Q40251294 | ||
| Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening | Q42238439 | ||
| QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States | Q43663890 | ||
| Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. | Q45048517 | ||
| Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report | Q45180236 | ||
| Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea | Q45387141 | ||
| WHO's 2013 global report on tuberculosis: successes, threats, and opportunities | Q46203889 | ||
| Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. | Q47652162 | ||
| Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers | Q57212364 | ||
| Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country | Q81823239 | ||
| Safety profile of IBD therapeutics: infectious risks | Q84960693 | ||
| ??? | Q57227541 | ||
| P433 | issue | 2 | |
| P921 | main subject | tuberculosis | Q12204 |
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 173-179 | |
| P577 | publication date | 2015-01-21 | |
| P1433 | published in | Journal of Korean Medical Science | Q24039955 |
| P1476 | title | The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers | |
| P478 | volume | 30 |
| Q92756728 | Bacteriologically Determined De Novo Tuberculosis during Tumor Necrosis Factor-α Inhibitor Therapy |
| Q58856028 | Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study |
| Q59131827 | Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease |
| Q57471145 | Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting |
| Q40102525 | Negative latent tuberculosis at time of incarceration: identifying a very high-risk group for infection. |
| Q38797602 | Reactivation tuberculosis: role of surveillance |
| Q40676195 | Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis |
| Q38753468 | Review of pulmonary adverse effects of infliximab therapy in Crohn's disease |
| Q39116859 | Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea |
| Q39044550 | Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists |
Search more.